These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
298 related items for PubMed ID: 7830728
1. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW. N Engl J Med; 1995 Feb 23; 332(8):481-7. PubMed ID: 7830728 [Abstract] [Full Text] [Related]
2. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. N Engl J Med; 1995 Feb 23; 332(8):488-93. PubMed ID: 7830729 [Abstract] [Full Text] [Related]
3. Effect of exercise on coronary endothelial function in patients with coronary artery disease. Hambrecht R, Wolf A, Gielen S, Linke A, Hofer J, Erbs S, Schoene N, Schuler G. N Engl J Med; 2000 Feb 17; 342(7):454-60. PubMed ID: 10675425 [Abstract] [Full Text] [Related]
4. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. Brown G, Albers JJ, Fisher LD, Schaefer SM, Lin JT, Kaplan C, Zhao XQ, Bisson BD, Fitzpatrick VF, Dodge HT. N Engl J Med; 1990 Nov 08; 323(19):1289-98. PubMed ID: 2215615 [Abstract] [Full Text] [Related]
5. [Improvement of endothelial function in patients with hypercholesterolemia and normal coronary arteries with lipid-lowering therapy]. Iràculis E, Cequier A, Sabaté M, Pintó X, Antoni Gómez-Hospital J, Mauri J, García Del Blanco B, Fernández-Nofrerias E, Palom X, Jara F, Esplugas E. Rev Esp Cardiol; 2001 Jun 08; 54(6):685-92. PubMed ID: 11412774 [Abstract] [Full Text] [Related]
6. Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function. Wassmann S, Faul A, Hennen B, Scheller B, Böhm M, Nickenig G. Circ Res; 2003 Oct 31; 93(9):e98-103. PubMed ID: 14551237 [Abstract] [Full Text] [Related]
7. Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study. Stone PH, Lloyd-Jones DM, Kinlay S, Frei B, Carlson W, Rubenstein J, Andrews TC, Johnstone M, Sopko G, Cole H, Orav J, Selwyn AP, Creager MA, Vascular Basis Study Group. Circulation; 2005 Apr 12; 111(14):1747-55. PubMed ID: 15809368 [Abstract] [Full Text] [Related]
8. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A. N Engl J Med; 1993 Jun 10; 328(23):1659-64. PubMed ID: 8487824 [Abstract] [Full Text] [Related]
9. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. Yeung AC, Vekshtein VI, Krantz DS, Vita JA, Ryan TJ, Ganz P, Selwyn AP. N Engl J Med; 1991 Nov 28; 325(22):1551-6. PubMed ID: 1944439 [Abstract] [Full Text] [Related]
10. Effect of intensive versus moderate lipid lowering on endothelial function and vascular responsiveness to angiotensin II in stable coronary artery disease. van der Harst P, Wagenaar LJ, Buikema H, Voors AA, Plokker HW, Morshuis WJ, Six AJ, Boonstra PW, Nickenig G, Wassmann S, van Veldhuisen DJ, van Gilst WH. Am J Cardiol; 2005 Nov 15; 96(10):1361-4. PubMed ID: 16275178 [Abstract] [Full Text] [Related]
11. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P. N Engl J Med; 1986 Oct 23; 315(17):1046-51. PubMed ID: 3093861 [Abstract] [Full Text] [Related]
12. Close relationship between the vasodilator response to acetylcholine in the brachial and coronary artery in suspected coronary artery disease. Takase B, Hamabe A, Satomura K, Akima T, Uehata A, Ohsuzu F, Ishihara M, Kurita A. Int J Cardiol; 2005 Oct 20; 105(1):58-66. PubMed ID: 16207546 [Abstract] [Full Text] [Related]
13. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. Pitt B, Waters D, Brown WV, van Boven AJ, Schwartz L, Title LM, Eisenberg D, Shurzinske L, McCormick LS. N Engl J Med; 1999 Jul 08; 341(2):70-6. PubMed ID: 10395630 [Abstract] [Full Text] [Related]
14. Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group. Weintraub WS, Boccuzzi SJ, Klein JL, Kosinski AS, King SB, Ivanhoe R, Cedarholm JC, Stillabower ME, Talley JD, DeMaio SJ. N Engl J Med; 1994 Nov 17; 331(20):1331-7. PubMed ID: 7935702 [Abstract] [Full Text] [Related]
15. Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial. Waters D, Higginson L, Gladstone P, Kimball B, Le May M, Boccuzzi SJ, Lespérance J. Circulation; 1994 Mar 17; 89(3):959-68. PubMed ID: 8124836 [Abstract] [Full Text] [Related]